Details

Autor(en) / Beteiligte

• Kato, Takao
• Yaku, Hidenori
• Morimoto, Takeshi
• Inuzuka, Yasutaka
• Tamaki, Yodo
• Ozasa, Neiko
• Yamamoto, Erika
• Yoshikawa, Yusuke
• Kitai, Takeshi
• Taniguchi, Ryoji
• Iguchi, Moritake
• Kato, Masashi
• Takahashi, Mamoru
• Jinnai, Toshikazu
• Ikeda, Tomoyuki
• Nagao, Kazuya
• Kawai, Takafumi
• Komasa, Akihiro
• Nishikawa, Ryusuke
• Kawase, Yuichi
• Morinaga, Takashi
• Kawato, Mitsunori
• Seko, Yuta
• Shiba, Masayuki
• Toyofuku, Mamoru
• Furukawa, Yutaka
• Ando, Kenji
• Kadota, Kazushige
• Sato, Yukihito
• Kuwahara, Koichiro
• Kimura, Takeshi
• Lionetti, Vincenzo

Titel

Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study

Ist Teil von

• PloS one, 2020-12, Vol.15 (12), p.e0243818-e0243818

Ort / Verlag

United States: Public Library of Science

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• Despite the prognostic importance of hypoalbuminemia, the prognostic implication of a change in albumin levels has not been fully investigated during hospitalization in patients with acute decompensated heart failure (ADHF). Using the data from the Kyoto Congestive Heart Failure registry on 3160 patients who were discharged alive for acute heart failure hospitalization and in whom the change in albumin levels was calculated at discharge, we evaluated the association with an increase in serum albumin levels from admission to discharge and clinical outcomes by a multivariable Cox hazard model. The primary outcome measure was a composite of all-cause death or hospitalization for heart failure. Patients with increased albumin levels (N = 1083, 34.3%) were younger and less often had smaller body mass index and renal dysfunction than those with no increase in albumin levels (N = 2077, 65.7%). Median follow-up was 475 days with a 96% 1-year follow-up rate. Relative to the group with no increase in albumin levels, the lower risk of the increased albumin group remained significant for the primary outcome measure (hazard ratio: 0.78, 95% confidence interval: 0.69-0.90: P = 0.0004) after adjusting for confounders including baseline albumin levels. When stratified by the quartiles of baseline albumin levels, the favorable effect of increased albumin was more pronounced in the lower quartiles of albumin levels, but without a significant interaction effect (interaction P = 0.49). Independent of baseline albumin levels, an increase in albumin during index hospitalization was associated with a lower 1-year risk for a composite of all-cause death and hospitalization in patients with acute heart failure.